Literature DB >> 10832701

Adeno-associated and herpes simplex viruses as vectors for gene transfer to the corneal endothelium.

T Hudde1, S A Rayner, M De Alwis, A J Thrasher, J Smith, R S Coffin, A J George, D F Larkin.   

Abstract

PURPOSE: We examined the efficacy and cytopathogenicity of adeno-associated (AAV) and herpes simplex viruses (HSV) as vectors for gene transfer to corneal endothelial cells (CECs).
METHODS: Recombinant AAV and HSV were examined for their ability to deliver a lacZ histochemical marker gene to whole-thickness rabbit and human corneas ex vivo. Transgene expression was detected with histochemistry and quantified by a colorimetric assay.
RESULTS: Rabbit and human corneas transduced with AAV showed increasing numbers of cells expressing marker gene over a 3- to 4-week period. Using 2.5 x 10(6) or 1.5 x 10(7) infective units for rabbit and human corneal specimens, respectively, approximately 2% of CECs expressed the reporter gene. HSV (10(6) plaque-forming units/specimen) transduced approximately 5% of rabbit and human CECs but showed cytotoxicity. In contrast to the duration of recombinant AAV-mediated lacZ expression, recombinant HSV expression was maximal at day 1 and declined to low levels at day 7.
CONCLUSION: AAV is a promising vector, but its usefulness for corneal transduction is currently limited by the technical difficulties preparing high titres. The HSV vector examined is efficient but needs further genetic modification to prolong transgene expression and reduce its toxicity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10832701     DOI: 10.1097/00003226-200005000-00022

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  12 in total

1.  Is ex vivo adenovirus mediated gene transfer a therapeutic option for the treatment of corneal diseases?

Authors:  T Ritter; N Gong; U Pleyer
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

2.  Lentiviral mediated gene delivery to the anterior chamber of rodent eyes.

Authors:  Pratap Challa; Coralia Luna; Paloma B Liton; Beth Chamblin; John Wakefield; Ram Ramabhadran; David L Epstein; Pedro Gonzalez
Journal:  Mol Vis       Date:  2005-06-21       Impact factor: 2.367

3.  High-level gene transfer to the cornea using electroporation.

Authors:  Kathleen Blair-Parks; Bonnie C Weston; David A Dean
Journal:  J Gene Med       Date:  2002 Jan-Feb       Impact factor: 4.565

4.  Multi-gene targeted antiangiogenic therapies for experimental corneal neovascularization.

Authors:  Peng Chen; Hongmei Yin; Yao Wang; Jing Mi; Wenxiao He; Lixin Xie; Yiqiang Wang
Journal:  Mol Vis       Date:  2010-02-27       Impact factor: 2.367

Review 5.  Gene therapy in corneal transplantation.

Authors:  Yureeda Qazi; Pedram Hamrah
Journal:  Semin Ophthalmol       Date:  2013 Sep-Nov       Impact factor: 1.975

6.  Comparison of non-viral methods to genetically modify and enrich populations of primary human corneal endothelial cells.

Authors:  Christoph Engler; Clare Kelliher; Karl J Wahlin; Caroline L Speck; Albert S Jun
Journal:  Mol Vis       Date:  2009-04-01       Impact factor: 2.367

7.  Oligopeptide-mediated gene transfer into mouse corneal endothelial cells: expression, design optimization, uptake mechanism and nuclear localization.

Authors:  Wei Yang Seow; Yi-Yan Yang; Andrew J T George
Journal:  Nucleic Acids Res       Date:  2009-08-19       Impact factor: 16.971

Review 8.  Strategies for local gene therapy of corneal allograft rejection.

Authors:  Pho Nguyen; Samuel C Yiu
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Jan-Mar

9.  Targeting herpetic keratitis by gene therapy.

Authors:  Hossein Mostafa Elbadawy; Marine Gailledrat; Carole Desseaux; Diego Ponzin; Stefano Ferrari
Journal:  J Ophthalmol       Date:  2012-12-26       Impact factor: 1.909

Review 10.  Novel insights into gene therapy in the cornea.

Authors:  Rajiv R Mohan; Lynn M Martin; Nishant R Sinha
Journal:  Exp Eye Res       Date:  2020-11-16       Impact factor: 3.770

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.